首页|sLAG-3、PGR联合Hp抗体检测对早期胃癌的诊断价值

sLAG-3、PGR联合Hp抗体检测对早期胃癌的诊断价值

扫码查看
目的:研究可溶性淋巴细胞活化基因-3(soluble lymphocyte activation gene-3,sLAG-3)、胃蛋白酶原Ⅰ(PGⅠ)/胃蛋白酶原Ⅱ(PGⅡ)比值(PGR)联合幽门螺杆菌(helicobacter pylori,Hp)抗体分型检测对早期胃癌的诊断价值.方法:选择2020年1月—2023年6月于赣州市肿瘤医院就诊的120例早期胃癌患者作为研究组,选择同期于本院就诊的癌前病变患者 72 例作为对照组,进行回顾性分析.比较两组sLAG-3、PGR及Hp抗体检测情况,并采用受试者操作特征(ROC)曲线分析上述三项指标单独及其联合诊断对早期胃癌的诊断价值.同时,比较不同Hp抗体检测结果的癌前病变、早期胃癌患者的sLAG-3、PGR.结果:研究组sLAG-3 高于对照组,PGR显著低于对照组(P<0.05);研究组CagA-128kD、VacA-110kD、VacA-90kD、UreA及UreB阳性率均显著高于对照组(P<0.05).Hp抗体阳性患者的sLAG-3 显著高于Hp抗体阴性患者,PGR低于Hp抗体阴性患者,差异均有统计学意义(P<0.05).由ROC曲线得知,sLAG-3 的敏感度为 55.00%,特异度为 76.39%,截断值为 256.37 ng/mL;PGR的敏感度为 70.00%,特异度为 86.11%,截断值为 2.32;Hp抗体的敏感度为 77.50%,特异度为 63.89%;联合诊断的敏感度为 85.00%,特异度为 79.17%.结论:sLAG-3、PGR单独诊断早期胃癌时具有较高的特异度,Hp抗体具有较高的敏感度,上述指标联合诊断早期胃癌的效能最高.
Diagnostic Value of sLAG-3,PGR Combined with Hp Antibody Detection on Early Gastric Cancer
Objective:To study the diagnostic value of soluble lymphocyte activation gene-3(sLAG-3),pepsinogen Ⅰ(PGⅠ)/pepsinogen Ⅱ(PGⅡ)ratio(PGR)combined with helicobacter pylori(Hp)antibody typing detection on early gastric cancer.Method:A total of 120 patients with early gastric cancer treated in Ganzhou Cancer Hospital from January 2020 to June 2023 were selected as the study group,and 72 patients with precancerous lesions treated in our hospital during the same period were selected as the control group for retrospective analysis.The detection of sLAG-3,PGR and Hp antibody were compared between the two groups,and the value of single and combined diagnosis of these three parameters in the diagnosis of early gastric cancer were analyzed by receiver operating characteristic(ROC)curve.At the same time,sLAG-3 and PGR of precancerous lesions and early gastric cancer patients with different Hp antibody detection results were compared.Result:sLAG-3 in the study group was higher than that in the control group,and PGR was significantly lower than that in the control group(P<0.05).The positive rates of CagA-128kD,VacA-110kD,VacA-90kD,UreA and UreB in study group were significantly higher than those in control group(P<0.05).sLAG-3 of Hp antibody positive patients were significantly higher than those of Hp antibody negative patients,and PGR was lower than that of Hp antibody negative patients,the differences were statistically significant(P<0.05).ROC curve shows that the sensitivity,specificity and cut-off value of sLAG-3 were 55.00%,76.39%and 256.37 ng/mL,respectively,the sensitivity,specificity and cut-off value of PGR were 70.00%,86.11%and 2.32,respectively,the sensitivity and specificity of Hp antibody were 77.50%and 63.89%,respectively,the sensitivity and specificity of combined diagnosis were 85.00%and 79.17%,respectively.Conclusion:sLAG-3 and PGR have high specificity in the diagnosis of early gastric cancer alone,and Hp antibody has high sensitivity,the combination of the above indexes has the highest efficiency in the diagnosis of early gastric cancer.

Soluble lymphocyte activation gene-3Pepsinogen ⅠPepsinogen ⅡHelicobacter pyloriEarly gastric cancer

李慧娟

展开 >

赣州市肿瘤医院病理科 江西 赣州 341000

可溶性淋巴细胞活化基因-3 胃蛋白酶原Ⅰ 胃蛋白酶原Ⅱ 幽门螺杆菌 早期胃癌

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(26)